This trial is testing a new heart pump to see if it is safe and effective in helping people with heart problems recover.
- Heart Failure
- Acute Heart Failure
2 Primary · 7 Secondary · Reporting Duration: From date of enrollment to 28 days or discharge from hospital & 90 days post-implant
1 Treatment Group
Subjects receiving the Impella BTR
1 of 1
10 Total Participants · 1 Treatment Group
Primary Treatment: Impella BTR · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the overall number of participants involved in this research initiative?
"Affirmative. Per the clinicaltrials.gov data, this medical study is currently enrolling patients; it was first published on April 20th 2022 and last modified on May 23rd 2022. 10 individuals must be recruited from 1 centre for participation in the trial." - Anonymous Online Contributor
Are enrollees being accepted into this clinical experiment currently?
"Affirmative. According to information on clinicaltrials.gov, this investigation is still recruiting patients - with the original post going up on April 20th 2022 and the last edit being made on May 23rd 2022. The study is looking for 10 individuals from a single medical centre." - Anonymous Online Contributor